|Year : 2018 | Volume
| Issue : 1 | Page : 19-25
Vitamin D status in patients with type-2 diabetes mellitus in Riyadh City, Saudi Arabia
Mysara M Mogahed
Department of Internal Medicine, Faculty of Medicine, Benha University, Banha; Department of Internal Medicine, Rafa Medical Center, Riyadh City, Egypt
|Date of Submission||31-Jul-2017|
|Date of Acceptance||08-Jan-2018|
|Date of Web Publication||24-May-2018|
Mysara M Mogahed
Department of Internal Medicine, Faculty of Medicine, Benha University, Banha
Source of Support: None, Conflict of Interest: None
Background Type-2 diabetes mellitus (T2DM) is a progressive and chronic disease characterized by both β-cell dysfunction and increased insulin resistance. Vitamin D is a crucial factor in the development of T2DM because it is necessary for normal insulin secretion. Despite ample sunshine, vitamin D deficiency is common in the Middle East.
Objective To report the vitamin D status and its impact on the people in Riyadh City, Saudi Arabia, with T2DM.
Patients and methods The study was carried out on 100 patients of 31–79 years old with T2DM. According to their vitamin D status, they were classified into three groups: group 1 (deficient, vitamin D: <20 ng/ml), group 2 (insufficient, vitamin D: 20–30 ng/ml), and group 3 (normal, vitamin D: >30 ng/ml). All were subjected to history taking, clinical examination, and assessment of fasting blood samples of serum concentrations of 25-hydroxy vitamin D [s-25(OH)D], blood glucose, glycated hemoglobin, lipid profile, liver enzymes (alanine transaminase and aspartate transaminase), urea and creatinine.
Results Inadequate vitamin D level was observed in 80% of the participants, with a mean s-25(OH)D of 18.3±10.9 ng/ml. S-25(OH)D correlated negatively with fasting blood sugar (FBS) (P=0.008), with cholesterol and low-density lipoprotein (P=0.012 and 0.003, respectively). The low vitamin D status was strongly associated with poor glycemic control (P=0.001) and in females (P=0.002). There was no significant association between s-25(OH)D level and different age groups.
Conclusion There is an overwhelming prevalence of vitamin D deficiency in our sample of Saudi diabetic patients. Association of low vitamin D status with poor glycemic control and atherogenic lipid profile suggests a role of vitamin D in the control of T2DM and dyslipidemia and the importance of early detection of its deficiency and vitamin D supplementation.
Keywords: type-2 diabetes, vitamin D, Saudi Arabia
|How to cite this article:|
Mogahed MM. Vitamin D status in patients with type-2 diabetes mellitus in Riyadh City, Saudi Arabia. Kasr Al Ainy Med J 2018;24:19-25
|How to cite this URL:|
Mogahed MM. Vitamin D status in patients with type-2 diabetes mellitus in Riyadh City, Saudi Arabia. Kasr Al Ainy Med J [serial online] 2018 [cited 2019 Sep 15];24:19-25. Available from: http://www.kamj.eg.net/text.asp?2018/24/1/19/233106
| Introduction|| |
Type-2 diabetes mellitus (aspartate transaminase) is a progressive and chronic disease characterized by both β-cell dysfunction and increased insulin resistance, defined as the inadequate response of skeletal muscle, liver, and adipose tissue to endogenous insulin secretions, and few drugs ameliorate increases in insulin resistance .
Since the discovery of oil in the Arabian Gulf area in the 1950s, there had been dramatic increase in the incidence of metabolic disorders especially diabetes, mainly due to changes in the pattern of lifestyle and food intake ,.
Saudi Arabia is currently at the top in the list of Middle East countries with the highest number of estimated cases of diabetes mellitus . The prevalence of T2DM in Saudi Arabia is around 23.7% of the total population which is the highest by percentage in Asia .
Vitamin D is nature’s own product; it is produced in the skin through the action of sunlight on 7-dehydrocholestrol . Vitamin D has been suggested to have a great role in global health not only in the musculoskeletal system but also in cellular proliferation and differentiation, immune system modulation, inhibition of rennin synthesis and erythropoiesis .
Vitamin D deficiency is a crucial factor in the development of T2DM. Vitamin D is believed to improve the body’s sensitivity to insulin and thus reduce the risk of insulin resistance. It can also regulate the production of insulin in the pancreas through control of the insulin receptor gene . However, the link between vitamin D status and diabetes still remains poorly understood.
In the Middle East, despite ample sunshine, vitamin D deficiency is common due to cultural practice and dark skin color . Few studies from the Middle East have examined the association between vitamin D status and diabetes ,,.
As a result, this relationship needs to be specifically explored in different populations, including the Middle East. The aim of this research, therefore, was to clarify vitamin D status in the Saudi Arabian people with T2DM.
| Patients and methods|| |
According to The American Diabetic Association (2015) . Fasting glucose equal to or greater than 126 mg/dl (7.0 mmol/l) or glucose concentration 2 h after the administration of 75 g oral glucose load equal to or greater than 200 mg/dl (11.1 mmol/l). Random glucose equal to or greater than 200 mg/dl or glycated hemoglobin (HbA1c) equal to or greater than 6.5%; after taking informed consent of each participants to participate in the study we identified 100 patients of 31–79 years old with T2DM who were treated in an outpatient clinic of Endocrinology and Metabolism in Riyadh City, Saudi Arabia from January 2016 to January 2017.
According to Endocrine Society Clinical Practice Guideline of vitamin D deficiency . Vitamin D deficiency was defined as 25-hydroxy vitamin D [25(OH)D] of less than 20 ng/ml (<50 nmol/l), vitamin D insufficiency was defined as a 25(OH)D between 20 and 30 ng/ml (50–75 nmol/l). The normal serum concentration 25-hydroxy vitamin D [s-25(OH)D] was defined as at least 30 ng/ml (≥75 nmol/l); according to their vitamin D levels, the study participants were classified into three groups:
- Group 1: less than 20 ng/ml.
- Group 2: 20–30 ng/ml.
- Group 3: more than 30 ng/ml.
Exclusion criteria for the studied groups:
- Patients with type 1 diabetes.
- Pregnant and lactating women.
- Patients with hepatic or renal diseases.
- Patients who had received supplements containing vitamin D before testing.
Individuals of the studied groups were subjected to the following:
- Full history taking.
- Thorough clinical examination.
- Laboratory investigations.
The laboratory investigations included:
Fasting blood samples were collected in aseptic syringes and were equally aliquoted in red, gray, and lavender vacutainers. Red-capped vacutainers were used for the estimation of lipid profile, liver enzymes (alanine transaminase and aspartate transaminase), urea, creatinine and vitamin D (25 hydroxycholecalciferol); gray-capped vacutainers were used for the estimation of blood sugar and lavender vacutainers were used for the estimation of HbA1c.
25(OH)D Total assay was estimated in VIDAS [BIOM´RIEUX MINI Vidas (France) analyzer] by enzyme-linked fluorescent assay technique. Glucose was estimated by glucose oxidase and a modified Trineder color reaction, catalyzed by the enzyme peroxidase. Fasting lipid profile and liver enzymes were estimated by Konelab kits using Indiko fully automated analyzers. HbA1c was measured in clover A1c using the well-established method of boronate affinity.
The collected data were summarized in terms of mean±SD for quantitative data and frequency and percentage for qualitative data. Analysis was done using analysis of variance (F-test) using post-hoc least significant difference for multiple comparisons and Student’s t-test for quantitative data. Fischer’s exact test is used for analysis of qualitative data. A P value of less than 0.05 was considered statistically significant. All statistical analyses were carried out using the computerized statistical package for the social sciences (SPSS, version 20.0 for Windows; SPSS Inc., Chicago, Illinois, USA).
| Results|| |
A total of 100 diabetic patients (49% were men and 51% women) were enrolled in this study. The mean age of the study group was 51.8±12.3 year. The mean HbA1c among diabetic patients was 9.4±1.9. The average serum 25(OH)D value was 18.3±10.9 ng/ml ([Table 1]).
According to the vitamin D level, the patients were classified into three groups: group 1 (deficient, <20 ng/ml), group 2 (insufficient, 20 : 30/ml) and group 3 (normal, >30 ng/ml).The results were analyzed using the F-test to compare data for group 1, group 2, and group 3 as shown in [Table 2].
Seventy-one (71%) patients had vitamin D deficiency, only 9% had vitamin D insufficiency, and one-fifth (20%) were normal with significant statistical difference in their vitamin D level between the three groups (P=0.001). FBS was significantly related to the vitamin D level with P=0.008.The total cholesterol and low-density lipoprotein (LDL) were also significantly related to the vitamin D status with P=0.012 and 0.003, respectively.
As regards other biochemical parameters, there was no statistically significant difference among the study groups.
[Figure 1] shows the level of HbA1c in different vitamin D groups: 1, 2, and 3, where HbA1c was significantly higher in group 1 (9.67) and group 2 (9.63) than in group 3 (8.37) with P=0.023.
|Figure 1 Mean glycated hemoglobin (HbA1c) among different groups of vitamin D level.|
Click here to view
In comparing the different levels of HbA1c among the studied groups to assess the role of vitamin D deficiency in glycemic control, it was found that the number of patients with HbA1c (>8) was highest in group 1 (vitamin D-deficient group) 54 (76.1%), which was statistically significant with Fischer’s exact test=18.23 and P=0.001 ([Table 3]).
[Table 4] shows the vitamin D status in different age groups; vitamin D deficiency was maximally observed in the fifth decade (41–50 years) 22 (31%) patients, while the normal vitamin D level was maximally observed in the sixth decade (51–60 years), eight (40%) patients. However, there was no statistically significant difference between different age groups (P=0.06).
As regards sex distribution, in vitamin D-deficient patients (group 1): men were more predominant, 41 (57.7%); while in group 2 and group 3, women were more predominant, nine (100%) and 12 (60%), respectively and the results were statistically significant (P=0.002) ([Table 4]).
| Discussion|| |
Vitamin D deficiency has strong argument in its effect on pathogenicity and development of T2DM. The diverse effect of vitamin D on glucose and calcium homeostasis has made it an ideal contender to know its role in glycemic control in T2DM. So our study was conducted to identify vitamin D status in diabetic patients and its relation to glycemic control and different biochemical parameters.
The present study shows that the prevalence of vitamin D deficiency in diabetic participants was alarmingly high, nearly more than 2/3 (71%) of the study participants had vitamin D deficiency [s-25(OH)D: <20 ng/ml] and 9% had vitamin D insufficiency [s-25(OH)D: 20–30 ng/ml]. These together suggest that 80% of the studied diabetic patients had inadequate vitamin D level, which was in accordance with the findings of Zhang et al. , who studied the prevalence of diabetes in vitamin D-deficient Kuwaiti adults and also found that 80% of Kuwaiti adults had inadequate vitamin D level and is nearly similar to the results obtained by Sadiya et al. , who explore the vitamin D status and its relationship with metabolic markers in persons with obesity and T2DM in the UAE and reported that 83.2% of Emirati diabetic patients had vitamin D deficiency. But it was lower than the findings of Alhumaidi et al. , who study vitamin D deficiency in patients with T2DM in the southern region of Saudi Arabia and reported that the prevalence of inadequate vitamin D level was 98.5% in their studied groups which was considered the highest reported prevalence in Saudi Arabia.
The mean vitamin D level in the present study was 18.3±10.9 ng/ml. This result was higher than the finding of Zhang et al.  who reported a median vitamin D level of 13.8 ng/ml; the results obtained by Sadiya et al.  who reported a mean vitamin D level of 33.8±20.3 nmol/l=13.5±8.1 ng/ml, Alhumaidi et al.  who also found that the vitamin D level in his diabetic participants was 15.8±7.5 ng/ml, Dabbour et al.  who studied vitamin D status in T2DM patients in the Makkah region of Saudi Arabia and it was 6.17±2.47 ng/ml and Kafeshani et al.  who studied the vitamin D level in diabetic and nondiabetic patients in Isfahan, Iran and found that the mean vitamin D among diabetic patients was 27.44±3.66 nmol/l=10.97±1.46 ng/ml. It was also nearly similar to the findings of Chaudhary et al.  who study vitamin D level in diabetic Indians and it had a mean of 19.09±5.34 ng/ml.
The low vitamin D status in our study population may result from reduced exposure to sunshine and low dietary intake of fortified products and dietary supplements. Researchers have shown that vitamin D deficiency is highly prevalent among healthy Saudi women as well as men and is largely attributed to obesity, poor exposure to sunlight, poor dietary vitamin D supplementation, sedentary lifestyle and lack of education, which in turn affects bone mineral density and bone turnover markers ,.
The present study demonstrated that FBS and HbA1c were significantly high in patients with low vitamin D status, which was in coincidence with the finding of Sadiya et al. , Chaudhary et al. , Swamy et al.  and Sehgal et al. , who evaluated vitamin D levels in diabetic Indians. It was also similar to the findings of Zhang et al.  who studied the vitamin D status in Chinese T2DM, Boyraz et al.  who compared the vitamin D level in Turkish diabetic patients on oral hypoglycemic agents and insulin treatment and Shenoy et al.  who studied the association between vitamin D, FBS, HbA1c, and fasting lipid profile in euglycemic Indians.
In the present study, low vitamin D status was strongly associated with poor glycemic control, where the highest level of HbA1c (>8) was present in 67.1% of group 1 (vitamin D deficient patients) which was in agreement with Chaudhary et al.  and Zhang et al. . This was in contrary to Sadiya et al.  and Olt  who studied the relationship between vitamin D and glycemic control in Turkish patients with T2DM and found nonsignificant association between low vitamin D status and poor glycemic control.
Taking into consideration that all the study participants are diabetics, we should pay our attention toward the possible role of vitamin D deficiency in T2DM which is thought to have several potential mechanisms, including increasing the formation of proinflammatory cytokines and acute-phase reactants, likely to increase low-grade inflammation, as well as the well-known promotion of insulin secretion from β-cells ,,. The efficacy of vitamin D in stimulating insulin release can be affected by vitamin D axis gene polymorphisms, such as those for the activating enzyme (vitamin D 1α-hydroxylase; CYP27B1) and the transport protein (vitamin D binding protein), as well as for vitamin D receptors (VDR) ,,,,,. In another study, variants of the VDRs in pancreatic β-cells, skeletal muscle, and adipose tissue were associated with variation in the effects of vitamin D on glucose metabolism . Certain vitamin D binding proteins and allelic variations in the VDR gene might also affect insulin secretion and glucose tolerance, which, in turn, might contribute to the genetic risk of T2DM .
In the present study, low vitamin D status was associated with atherogenic lipid profile. The low vitamin D status in the present study was associated with a significant increase in cholesterol and LDL, but with nonsignificant increase in triglyceride levels and also had a nonsignificant effect on high-density lipoprotein level which is in accordance with many studies like the study obtained by Sadiya et al.  and the study of Saedisomeolia et al.  who study the association between the serum level of vitamin D and lipid profiles in T2DM patients in Iran.
Moreover, several previous studies support that vitamin D deficiency alone directly affect the lipid profile irrespective of the diabetic status of the patients: Alhumaidi et al.  found that the mean vitamin D level was lower in nondiabetic than in diabetic individuals which was associated with a nonsignificant increase of cholesterol in the nondiabetic group and Shenoy et al.  who found that low vitamin D status was significantly associated with atherogenic lipid profile in euglycemic Indians.
It was suggested that vitamin D can modify the lipid profile by direct and indirect mechanisms. It can directly decrease triglyceride levels by increasing the activity of lipoprotein lipase in adiposity . It can also indirectly reduce the serum levels of total and LDL cholesterol as calcium interferes with fatty acid absorption through the formation of insoluble calcium–fatty complexes in the gut, resulting in increasing the conversion of cholesterol to bile acids  however, the relation to calcium was not included in the present study.
Regarding vitamin D status in different age groups, there was nonsignificant relation between vitamin D status and age in diabetic participants which was similar to the findings of Kafeshani et al.  and Shenoy et al.  and in contrast with many studies as those of Zhang et al. , Sadiya et al. , and Dabbour et al.  all found significant positive relation between vitamin D status and age. In the present study, there was no particular age group associated with low vitamin D status in Saudi diabetic patients which mean that vitamin D deficiency can occur at any age as the general Saudi population are not exposed to sunlight and is characterized by lack of outdoor activities because of the hot weather most of the year, especially in Riyadh.
In the present study, female sex was significantly associated with lower vitamin D status which was in accordance with Zhang et al.  and in contrary to many previous studies who document a nonsignificant difference between men and women ,,,,. This can be explained by the fact that in the Arabic world, women had lower outdoor activities and the use of sunscreen before going outdoors. And specifically in Saudi Arabia all women wore their traditional black Abaya outdoors which reduced the surface area exposed to direct sunlight . The black clothing blocks 100% of ultraviolet-B radiation .
Limitation of the study: the present study is limited by the small number of patients and lack of lifestyle data. Parathyroid hormone, calcium, and other inflammatory markers were not measured and those can affect the islet β-cell function.
| Conclusion|| |
The purpose of the current study was to clarify vitamin D status in Saudi Arabian people with T2DM. The findings of this study suggest an alarmingly high prevalence of vitamin D deficiency, and low vitamin D status in patients with T2DM in Riyadh city in Saudi Arabia. The present data indicate that the availability of adequate sunlight alone is not sufficient for the prevention of vitamin D deficiency and raises awareness of hypovitaminosis D in the diabetic population, regardless of the geographic location. Also low vitamin D status was associated with poor glycemic control and atherogenic lipid profile in diabetic patients, which mean that early detection of vitamin D deficiency and supplementation may help in the improvement of glycemic control and prevent complications of T2DM and dyslipidemia.
Meanwhile, there was no significant relation between vitamin D status and different age groups and also a low vitamin D status was highly prevalent in women, which suggest that deficiency can occur at any age specially in women, so any program directed to improve vitamin D status in diabetics should include encouraging outdoor activities, exposure to direct sunlight (may be in health clubs), early detection, and supplementation of vitamin D should be directed toward all diabetic individuals of any age specially women.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Holick MF. Vitamin D: extraskeletal health. Endocrinol Metab Clin North Am 2010; 39:381–400.
Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 2009; 16:268–280.
Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson RT, Rao A et al.
High prevalence of metabolic syndrome among Kuwaiti adults − a wake-up call for public health intervention. Int J Environ Res Public Health 2012; 9:1984–1996.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year2000 and projections for 2030. Diabetes Care 2004; 27:1047–1053.
El-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudis. East Mediterr Health J 2000; 6:276–8227.
Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 2012; 126:270–277.
De Luca HF. Overview of general physiologic features and functions vitamin D. Am J Clin Nutr 2004; 80:1689s–1696s.
Nada AM. Correlation between vitamin D3 and fasting plasma glucose, A1Cand serum lipids in non-diabetic subjects. ZUMJ 2013; 19:4.
9El-Sonbaty MR, Abdul-Ghaffar NU. Vitamin D deficiency in veiled Kuwaiti women. Eur J Clin Nutr 1996; 50:315–318.
Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yakout SM, Aljohani NJ et al.
Lower vitamin D status is more common among Saudi adults with diabetes mellitus type 1 than in non-diabetics. BMC Public Health 2014; 14:153.
Alhumaidi M, Agha A, Dewish M. Vitamin D deficiency in patients with type-2 diabetes mellitus in southern region of Saudi Arabia. Maedica (Buchar) 2013; 8:231–236.
Sadiya A, Ahmed SM, Skaria S, Abusnana S. Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study. J Diabetes Res 2014; 2014:869307.
Standards of Medical Care in Diabetes. Classification and diagnosis of diabetes. Diabetes Care 2015; 38(Suppl 1):S8–S16.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanely DA, Heaney RP et al.
Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911–1930.
Zhang FF, Al Hoot S, Al Zenki S, Alomirah H, Jamil KM, Rao A et al.
Vitamin D deficiency is associated with high prevalence of diabetes in Kuwaiti adults: results from a national survey. BMC Public Health 2016; 16:100.
Dabbour IR, Jazar AS, Azzeh FS. Vitamin D status in patients with type 2 diabetes mellitus in Makkah region of Saudi Arabia. Pakistan J Nutr 2016; 15:203–210.
Kafeshani M, Zarafshani M, Shokri-Moghaddam S, Ahmadi A, Nasri H. Serum 25-hydroxy vitamin D level in diabetic patients versus normal individuals; a pilot study. J Parathyroid Dis 2016; 4:40–43.
Chaudhary V, Bhaskar N, Gupta PD, Lamichhane A, Prasad S, Sodhi KS. Vitamin D and glycated hemoglobin (HbA1c) levels in type 2 diabetes mellitus. World J Pharm Pharm Sci 2016; 5:820–828.
Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM. Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 2011; 22:463–475.
Ardawi MS, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int 2012; 23:675–686.
Swamy M, Ganiger A, Prasad DS, Ratna S. Serum 25-hydroxy vitamin D levels in type 2 diabetes mellitus − a comparative study. Int J Clin Biochem Res 2016; 3:255–258.
Sehgal G, Singh J, Kumar S. Evaluation of serum 25-hydroxy vitamin D levels in type 2 diabetes mellitus patients. Int J Health Sci Res 2017; 7:137–140.
Zhang J, Ye J, Guo G, Lan Z, Xing L, Pan Z et al.
Vitamin D status is negatively correlated with insulin resistance in Chinese type 2 diabetes. Int J Endocrinol 2016; 2016:1794894.
Boyraz İ, Bilge U, Ünalacak M, Bilgin M. A comparison of 25(OH) vitamin D levels in patients with type 2 diabetes on oral hypoglycemic agents and insulin treatment. Biomed Res 2016; 27:1–5.
Shenoy V, Datta P, Prabhu K, Singh K. Association between vitamin D, fasting blood glucose, HbA1c and fasting lipid profile in euglycemic individuals. J Res Diabetes 2014; 2014:929743.
Olt S. Relationship between vitamin D and glycemic control in patients with type 2 diabetes mellitus. Int J ClinExp Med 2015; 8:19180–19183.
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and ß- cell dysfunction. Am J Clin Nutr 2004; 79:820–825.
García-Bailo B, Roke K, Mutch DM, El-Sohemy A, Badawi A. Association between circulating ascorbic acid, tocopherol, 25-hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study. Nutr Metab (Lond) 2012; 9:102.
Badawi A, Klip A, Haddad P, Cole ECD, Bailo GB, El-Sohemy A et al.
Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 2010; 3:173–186.
BaierL J, Dobberfuhl AM, PratleyR E, Hanson RL, Bogardus C. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in non diabetic Pima Indians. J Clin Endocrinol Metab 1998; 83:2993–2996.
McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ et al.
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997; 40:971–975.
Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH et al.
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 9:504–507.
Malecki MT, Klupa T, Wolkow P, Bochenski J, Wanic K, Sieradzki J. Association study of the vitamin D: 1 alpha hydroxylase (CYP1 alpha) gene and type 2 diabetes mellitus in a Polish population. Diabetes Metab 2003; 29:119–124.
García-Bailo B, Jamnik J, Da Costa LA, Badawi A, El-Sohemy A. Genetic variation in the vitamin D receptor, plasma 25-hydroxyvitamin D, and biomarkers of cardiometabolic disease in Caucasian young adults. J Nutrigenet Nutrigenomics 2013; 6:256–267.
Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D deficient rat in vivo. Endocrinology 1986; 119:84–90.
Bischoff HA, Borchers M, Gudat F, Duermuller U, Theiler R, Stahelin HB et al.
In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33:19–24.
Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K et al.
Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002; 51:2294–2300.
Saedisomeolia A, Taheri E, Djalali M, Moghadam AM, Orbani M. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metab Disord 2014; 13:7.
Wang JH, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P. Serum cholesterol and expression of Apo Aǀ, LXR ß and SREBP2 in vitamin D receptor knock-out mice. J Steroid Biochem Mol Biol 2009; 113:222–226.
Christensen R, Lorenzen JK, Svith CR, Bartels E, Melanson E, Saris W et al.
Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 2009; 10:475–486.
Al Attia HM, Ibrahim MA. The high prevalence of vitamin D inadequacy and dress style of women in the sunny UAE. Arch Osteoporos 2012; 7:307–310.
Holick MF. McCollum Award Lecture, 1994: vitamin D − new horizons for the 21st century. Am J Clin Nutr 1994; 60:619–630.
[Table 1], [Table 2], [Table 3], [Table 4]